Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression